Literature DB >> 19419270

Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization.

Reuven Friedmann1, David Raveh, Esther Zartzer, Bernard Rudensky, Ellen Broide, Denise Attias, Amos M Yinnon.   

Abstract

OBJECTIVE: To determine the rates of and risk factors for carriage and acquisition of extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae during hospitalization.
DESIGN: Cohort study.
SETTING: Shaare Zedek Medical Center, a 550-bed teaching hospital.
METHODS: During a 5-month period (February 1-June 30, 2004), 167 (8%) of 1,985 newly admitted general medical patients were enrolled in our study. Nasal, oropharyngeal, and rectal swab specimens were obtained at admission and every 2-3 days until hospital discharge or death. Enterobacteriaceae isolates were tested for ESBL, and Staphylococcus aureus isolates were tested for methicillin resistance.
RESULTS: Of the 167 patients enrolled in our study, 15 (9%) were identified as nasal carriers of methicillin-resistant S. aureus (MRSA) at admission, and 13 (8%) were rectal carriers of ESBL-producing Enterobacteriaceae at admission. Univariate risk factors for rectal carriage of ESBL-producing Enterobacteriaceae included female sex (odds ratio [OR], 11 [95% confidence interval {CI}, 1.4-238]; P < .05), nursing home residence (OR, 6.9 [95% CI, 1.8-27]; P < .01), recent antibiotic treatment (OR, 9.8 [95% CI, 1.7-74]; P < .05), and concomitant nasal carriage of MRSA and/or ESBL-producing Enterobacteriaceae (OR, 5.8 [95% CI, 1.2-26]; P < .01). Multivariate risk factors were female sex and recent antibiotic treatment. During hospitalization, 35 (21%) of 167 patients had acquired rectal carriage of ESBL-producing Enterobacteriaceae (P = .002, for trend analysis). Of the 12 patients who were still in the hospital 2 weeks after admission, 4 (33%) were carriers of ESBL-producing Enterobacteriaceae. Univariate risk factors for acquisition included an age of older than 65 years (P < .005), nursing home residence (OR 2.6, [95% CI, 0.98-2.6]), impaired cognition (OR, 4.8 [95% CI, 1.9-12]), recent antibiotic treatment (OR, 2.7 [95% CI, 0.9-8.3]), respiratory assistance (OR, 4.2 [95% CI, 1.2-14]), and prolonged hospitalization. Multivariate risk factors were an age of older than 65 years and broad-spectrum antibiotic therapy.
CONCLUSIONS: Rectal carriage of ESBL-producing Enterobacteriaceae occurred in 13 (8%) of 167 patients at admission to the medical departments of our hospital and in 4 (33%) of 12 patients still remaining in our hospital after 2 weeks.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19419270     DOI: 10.1086/597505

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  36 in total

1.  Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.

Authors:  B J Liss; J J Vehreschild; O A Cornely; M Hallek; G Fätkenheuer; H Wisplinghoff; H Seifert; M J G T Vehreschild
Journal:  Infection       Date:  2012-06-05       Impact factor: 3.553

2.  Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Matteo Bassetti; Francesco Giuseppe De Rosa; Teresa Spanu; Eugenia Di Meco; Angela Raffaella Losito; Andrea Parisini; Nicole Pagani; Roberto Cauda
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

3.  Identification of nasal colonization with β-lactamase-producing Enterobacteriaceae in patients, health care workers and students in Madagascar.

Authors:  Volker Micheel; Benedikt Hogan; Rivo Andry Rakotoarivelo; Raphael Rakotozandrindrainy; Fetra Razafimanatsoa; Tsiriniaina Razafindrabe; Jean Philibert Rakotondrainiarivelo; Sabine Crusius; Sven Poppert; Norbert Georg Schwarz; Jürgen May; Hagen Frickmann; Ralf Matthias Hagen
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

4.  Rectal swabs are suitable for quantifying the carriage load of KPC-producing carbapenem-resistant Enterobacteriaceae.

Authors:  A Lerner; J Romano; I Chmelnitsky; S Navon-Venezia; R Edgar; Y Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

5.  Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.

Authors:  S Meier; R Weber; R Zbinden; C Ruef; B Hasse
Journal:  Infection       Date:  2011-06-25       Impact factor: 3.553

6.  Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards.

Authors:  E Ruppé; A Pitsch; F Tubach; V de Lastours; F Chau; B Pasquet; J-C Lucet; A Andremont; B Fantin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-10       Impact factor: 3.267

7.  Risk factors for gastrointestinal tract colonization with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients.

Authors:  Jennifer H Han; Irving Nachamkin; Theoklis E Zaoutis; Susan E Coffin; Darren R Linkin; Neil O Fishman; Mark G Weiner; Baofeng Hu; Pam Tolomeo; Ebbing Lautenbach
Journal:  Infect Control Hosp Epidemiol       Date:  2012-10-23       Impact factor: 3.254

Review 8.  Pneumonia in frail older patients: an up to date.

Authors:  Marco Falcone; Francesco Blasi; Francesco Menichetti; Federico Pea; Francesco Violi
Journal:  Intern Emerg Med       Date:  2012-06-12       Impact factor: 3.397

9.  Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit.

Authors:  Keyvan Razazi; Lennie P G Derde; Marine Verachten; Patrick Legrand; Philippe Lesprit; Christian Brun-Buisson
Journal:  Intensive Care Med       Date:  2012-08-15       Impact factor: 17.440

10.  High rates of intestinal colonisation with fluoroquinolone-resistant ESBL-harbouring Enterobacteriaceae in hospitalised patients with antibiotic-associated diarrhoea.

Authors:  J Vervoort; M Gazin; M Kazma; T Kotlovsky; C Lammens; Y Carmeli; H Goossens; S Malhotra-Kumar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-07-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.